secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0000950170-24-112392
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Carmell receives Nasdaq deficiency notice for bid price below $1; 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified Carmell on Sept 30, 2024 that its common stock failed to maintain minimum $1 bid price for 31 consecutive business days.
- Company has until March 31, 2025 to regain compliance; closing bid price must be $1 for at least 10 consecutive days.
- If not cured, Nasdaq may grant an additional 180-day period if other listing standards are met.
- No immediate impact on trading of common stock (CTCX) or warrants (CTCXW); company evaluating options.
- There is no assurance that Carmell will be able to regain compliance with the Minimum Bid Price Requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000095017024112392/0000950170-24-112392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000095017024112392/ctcx-20240930.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-112392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer